Richard Roxburgh

University of Auckland — New Zealand

Neuroscience · Life Sciences

36h-index7.3kcitations176works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Neurodegenerative Diseases(79), Mitochondrial Function and Pathology(28), Neurogenetic and Muscular Disorders Research(25), Muscle Physiology and Disorders(17), Neurological disorders and treatments(17)

Publications175 total

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1
Neurology·2026
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study
PLoS ONE·2025Open Access
Moyamoya disease in a Pacific and Māori cohort
Journal of the Neurological Sciences·2025
Decision context and neurobehavioural disturbance in Huntington’s disease
Cognitive Affective & Behavioral Neuroscience·2025
3583 PINK1 parkinson’s disease in New Zealand
2025Open Access
YI2 Moyamoya disease in a Pacific and Māori Cohort
2025Open Access
357PLong-term vatiquinone treatment slows Friedreich’s ataxia disease progression relative to FACOMS natural history
Neuromuscular Disorders·2025
546PClinical research facilitated by the New Zealand neurogenetic registry & biobank
Neuromuscular Disorders·2025
446PStructural variants (SVs) underlying neurogenetic and neuromuscular diseases
Neuromuscular Disorders·2025
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1): protocol of an international natural history study
2025Open Access
Utility of neuromuscular ultrasound and comparison of NMUS with electrodiagnostic tests in dominant spinocerebellar ataxia
Clinical Neurophysiology·2025
Goal-directedness deficit in Huntington’s disease
Cognitive Affective & Behavioral Neuroscience·2025Open Access
Safety and Efficacy of DYNE-101 in Adults with DM1: Phase 1/2 ACHIEVE Trial Data (S16.003)
Neurology·2025· 2 cited
PINK1 Parkinson’s Disease in New Zealand: An Overview (P3-5.019)
Neurology·2025
Moyamoya Disease in the Pacific - A Novel Cohort (P2-2.012)
Neurology·2025
Epidemiology of spinal muscular atrophy in Aotearoa-New Zealand
Journal of Neuromuscular Diseases·2025Open Access
The genetics of motor neuron disease in New Zealand
Journal of the Neurological Sciences·2025· 2 citedOpen Access
Nerve ultrasound abnormality in RFC1 positive isolated sensory neuropathy is milder than in the full RFC1 canvas phenotype
Clinical Neurophysiology Practice·2025Open Access
Nerve ultrasound, neuronopathy and cough predict sensory neuropathy patients with <i>RFC1</i> expansions
Brain Communications·2025· 1 citedOpen Access
Disrupted Time Perception Underlies Motivational Disturbances in Huntington’s Disease
Timing & Time Perception·2024· 1 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Miriam Rodrigues(12), Stephen Sawcer(8), Hugh Dawkins(8), Anke Hensiek(7), Stuart Mossman(7), Patrick F. Chinnery(6), Lawrence Korngut(5), Craig Campbell(5), Anna Łusakowska(5), Hanns Lochmüller(5), Sarah J. Beecroft(5), Gianina Ravenscroft(5), Nigel G. Laing(5), Lynette J. Tippett(5), Virginia M. Hogg(5), Eoin Mulroy(5), Luciana Pelosi(5), Catherine L. Bladen(4), David Salgado(4), Soledad Monges(4)